Latest news - Johnson & Johnson
A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Press Releases - Johnson & Johnson
Explore all Johnson & Johnson published press releases by date and/or topic of news.
Johnson & Johnson Announces Plans to Accelerate Innovation, …
Nov 12, 2021 · The new Johnson & Johnson would continue to play a leading role in advancing the industry forward by creating novel solutions, bringing together treatments spanning …
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Johnson & Johnson single-shot vaccine showed strong and long-lasting protection in the real world The largest real-world evidence study for a COVID-19 vaccine reported to …
Latest COVID-19 News - Johnson & Johnson
Nov 30, 2021 · Discussions progress between Johnson & Johnson and the European Commission regarding Company’s investigational COVID-19 Vaccine. Learn more. Latest …
Johnson & Johnson: Changing health for humanity
What you need to know about Johnson & Johnson ’s 2023 transparency report. The annual report has just been released—here are key takeaways that showcase the company’s commitment to …
Investor Relations | Johnson & Johnson
Oct 15, 2024 · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson …
Johnson & Johnson Announces Key Drivers for Long-Term …
Dec 5, 2023 · At today’s meeting, members of Johnson & Johnson’s Executive Committee and leaders from the Innovative Medicine and MedTech businesses will highlight the Company’s …
Johnson & Johnson reports Q3 2024 results
Oct 15, 2024 · Johnson & Johnson is updating its 2024 guidance, including adjusted operational EPS guidance, to reflect improved performance and the impact from the recent acquisition of …
Positive New Data for Johnson & Johnson Single-Shot COVID-19 …
Jul 1, 2021 · In the ENSEMBLE trial, Johnson & Johnson’s single-dose COVID-19 vaccine was 85 percent effective against severe/critical disease and demonstrated protection against …